Open Beta
MetriLume

US marketsACH

SEC-sourced researchBeta

ACH

ACCENDRA HEALTH INC/VA/

Company comparison ↗

Data passport

CIK
0000075252
Exchange
NYSE
Business activity
Wholesale-Medical, Dental & Hospital Equipment & Supplies · SIC 5047
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 2,552,572,000.0000 USD; December 2024: 2,680,112,000.0000 USD; December 2025: 2,762,032,000.0000 USD2.8B USD0 USD0December 2023December 2024December 2025
ACH · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20232,552,572,000.0000Feb 20, 2026
December 20242,680,112,000.0000Feb 20, 2026
December 20252,762,032,000.0000Feb 20, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20252,762,032,000.0000-1,100,642,000.0000-101,790,000.00002,451,761,000.00002,912,739,000.0000Feb 20, 2026
December 20242,680,112,000.0000-362,686,000.0000161,495,000.00004,656,156,000.00004,069,792,000.0000Feb 20, 2026
December 20232,552,572,000.0000-41,301,000.0000740,710,000.0000——Feb 20, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

39/100
Profitability0
Growth53
Balance sheet0
Cash generation43
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$2.76BJan 1, 2025 – Dec 31, 2025Feb 20, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$2.68BJan 1, 2024 – Dec 31, 2024Feb 20, 202610-K
Net incomeNetIncomeLoss-$1.1BJan 1, 2025 – Dec 31, 2025Feb 20, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivitiesContinuingOperations-$101.79MJan 1, 2025 – Dec 31, 2025Feb 20, 202610-K
Total assetsAssets$2.45BDec 31, 2025Feb 20, 202610-K
Total liabilitiesLiabilities$2.91BDec 31, 2025Feb 20, 202610-K

New filings

Explore methodology ↗